首页> 外文期刊>Journal of cataract and refractive surgery >Consecutive myopia correction with transepithelial versus alcohol-assisted photorefractive keratectomy in contralateral eyes: One-year results
【24h】

Consecutive myopia correction with transepithelial versus alcohol-assisted photorefractive keratectomy in contralateral eyes: One-year results

机译:对侧眼连续经近视矫正并经上皮与酒精辅助光折射性角膜切除术:一年结果

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To compare the postoperative efficacy, safety, and higher-order-aberrations (HOAs) between transepithelial photorefractive keratectomy (PRK) and alcohol-assisted PRK in contralateral eyes. Setting: Private clinic, Utrecht, The Netherlands. Design: Comparative case series. Methods: Consecutive patients were randomized to have transepithelial PRK in 1 eye and alcohol-assisted PRK in the contralateral eye. In both eyes, aspheric treatments were planned with Custom Ablation Manager software and ablations performed with the Schwind Amaris system. Clinical outcomes were predictability, refraction, visual acuity, wavefront aberrations, and contrast and glare sensitivity. Paired t tests were applied for statistics. Results: The study evaluated 66 eyes (33 patients). All patients completed the 1-year follow-up. At 1-year, 97% of eyes in both groups achieved an uncorrected distance visual acuity (UDVA) of 0.1 logMAR or better. No eye lost 2 or more lines of corrected distance visual acuity (CDVA); 97% of transepithelial PRK eyes and 91% of alcohol-assisted PRK eyes were within ±0.50 diopter (D) of the targeted refraction. The postoperative mean spherical equivalent was +0.07 D ± 0.23 (SD) and +0.01 ± 0.27 D, respectively. Conclusions: The CDVA, UDVA, and safety outcomes between transepithelial PRK and alcohol-assisted PRK were comparable. Profiles for both techniques applied to regular corneas preserved the eye's natural HOAs. Transepithelial PRK is faster to perform and it is an all-laser procedure, which might be less stressful for the patient. Financial Disclosure: Mr. Ewering and Mr. Arba-Mosquera are employees of Schwind eye-tech-solutions. Dr. Luger has no financial or proprietary interest in any material or method mentioned.
机译:目的:比较对侧眼经皮上屈光性角膜切除术(PRK)和酒精辅助PRK的术后疗效,安全性和高阶像差(HOA)。地点:荷兰乌得勒支的私人诊所。设计:比较案例系列。方法:将连续患者随机分为1只眼经上皮PRK,对侧眼经酒精辅助PRK。两只眼睛都计划使用Custom Ablation Manager软件进行非球面治疗,并使用Schwind Amaris系统进行消融。临床结果为可预测性,屈光度,视敏度,波前像差以及对比度和眩光敏感度。配对的t检验用于统计学。结果:该研究评估了66眼(33例患者)。所有患者均完成了1年的随访。在1年时,两组中97%的眼睛的未矫正远视力(UDVA)为0.1 logMAR或更高。没有眼睛损失两行或更多行矫正远视力(CDVA); 97%的经上皮PRK眼和91%的酒精辅助PRK眼在目标屈光度的±0.50屈光度(D)内。术后平均球当量分别为+0.07 D±0.23(SD)和+0.01±0.27D。结论:CDVA,UDVA和经上皮PRK与酒精辅助PRK之间的安全性结果具有可比性。应用于常规角膜的两种技术的配置文件都保留了眼睛的自然HOA。经上皮PRK的执行速度更快,并且是全激光过程,对患者的压力可能较小。财务披露:Ewering先生和Arba-Mosquera先生是Schwind眼科技解决方案的员工。 Luger博士对上述任何材料或方法均无财务或所有权利益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号